Acute lymphoblastic leukaemia - blinatumomab - initial (induction) authority application form (PB210)

Use this form to apply for initial (induction) PBS-subsidised treatment with blinatumomab for acute lymphoblastic leukaemia.

Page last updated: 1 November 2023.
QC 36906